Atossa Therapeutics Inc.

NASDAQ: ATOS · Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
0.80
2.34%
After-hours: Aug 15, 2025, 07:37 PM EDT

Atossa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-28.72M -26.34M -25.5M -26.91M -25.91M -29.69M -30.09M -29.83M -31.61M -28.45M -26.96M -24.3M -21.49M -21.85M -20.61M -23.26M -21.55M -18.42M
Depreciation & Amortization
16K 16K 17K 27K 26K 25K 23K 11K 10K 9K 8K 7.74K 11.95K 15.74K 23K 30.52K 36.86K 43.45K
Stock-Based Compensation
2.88M 2.44M 2.29M 2.04M 2.21M 3.46M 4.62M 5.65M 6.39M 6.55M 6.79M 6.86M 6.99M 6.43M 5.27M 4.28M 3.15M 2.97M
Other Working Capital
-3.32M -1.99M -1.36M -1.76M 1.67M 1.52M 2.71M 3.83M 4.15M 1.45M -1.85M -3.46M -4.59M -2.41M -1.28M -575.83K -296.19K -1.01M
Other Non-Cash Items
4.01M 3.65M 3.65M 3.65M 531K 3.52M 6.61M 6.01M 5.49M 2.5M 931K 374K 2.17M 3.67M 3.75M 8.21M 6.42M 4.91M
Deferred Income Tax
n/a n/a n/a n/a -527K -527K -3.62M -3.02M -2.5M -2.5M 599K 1.16M 1.16M 1.16M 1.16M n/a n/a n/a
Change in Working Capital
-3.21M -2.05M -1.49M 1.65M 4.98M 4.59M 1.52M 1.29M 805K -1.02M -599K -2.47M -3.07M -1.54M -1.16M -590.45K -790.98K -648.42K
Operating Cash Flow
-25.02M -22.29M -21.03M -19.55M -18.68M -18.62M -20.94M -19.89M -21.42M -22.9M -20.76M -19.9M -17.55M -16.94M -16.47M -16.24M -15.86M -12.75M
Capital Expenditures
-19K -22K -19K -19K -10K -20K -14K -22K -27K -14K -27K -18.6K -22K -22K -9K -6.64K n/a -6.61K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a -2M -4.7M -4.7M -4.7M -2.7M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a -2K -4.7K -4.7K -17.7K -24.7K -22K -22K -9K n/a n/a -6.61K
Investing Cash Flow
-19K -22K -19K -19K -10K -20K -14K -2.02M -4.73M -4.71M -4.73M -2.72M -22K -22K -9K -6.64K n/a -6.61K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a -1.48M -1.48M -1.48M -1.48M 10.04M 18.95M 18.95M 18.95M 8.9M 5.99M 5.99M 5.99M 5.99M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.5M -4.5M -4.5M
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.87K -573K 9.62M 42.38M 51.83M 52.39M 42.2M
Financial Cash Flow
3.37M 3.47M 3.67M 304K -1.17M -1.27M -1.48M -1.48M n/a n/a n/a 718.00 679.65K 10.88M 113.3M 147.18M 150.83M 140.98M
Net Cash Flow
-21.67M -18.84M -17.38M -19.27M -19.86M -19.91M -22.43M -23.34M -26.15M -27.62M -25.49M -22.67M -16.9M -6.09M 96.82M 130.94M 134.97M 128.22M
Free Cash Flow
-25.04M -22.31M -21.05M -19.57M -18.69M -18.64M -20.95M -19.91M -21.45M -22.92M -20.79M -19.92M -17.58M -16.96M -16.48M -16.25M -15.86M -12.76M